BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22272898)

  • 21. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing type 2 diabetes mellitus in patients with obesity.
    Hauner H
    Treat Endocrinol; 2004; 3(4):223-32. PubMed ID: 16026105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
    Iepsen EW; Torekov SS; Holst JJ
    Expert Opin Pharmacother; 2014 Dec; 15(17):2487-500. PubMed ID: 25260877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of type 2 diabetes mellitus].
    Lyra R; Oliveira M; Lins D; Cavalcanti N
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):239-49. PubMed ID: 16767290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.
    Scheen AJ; Van Gaal LF
    Lancet Diabetes Endocrinol; 2014 Nov; 2(11):911-22. PubMed ID: 24731666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Diabetes and Cardiovascular Disease in Obesity.
    La Sala L; Pontiroli AE
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 29. Weight management in people with type 2 diabetes.
    Wu L; While A
    Br J Community Nurs; 2007 Sep; 12(9):390-7. PubMed ID: 18026001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.
    Heal DJ; Gosden J; Smith SL
    Br J Clin Pharmacol; 2009 Dec; 68(6):861-74. PubMed ID: 20002080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?
    Flatt PR
    Diab Vasc Dis Res; 2007 Jun; 4(2):151-3. PubMed ID: 17654450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporating practical lifestyle management for obesity.
    Bestermann WH
    J Fam Pract; 2010 May; 59(5 Suppl):S3-8. PubMed ID: 20544055
    [No Abstract]   [Full Text] [Related]  

  • 33. [Altering lifestyle and treating obesity, preventing type 2 diabetes?].
    Sauvanet JP
    Soins; 2004 Apr; (684 Pt 2):19-24. PubMed ID: 15151088
    [No Abstract]   [Full Text] [Related]  

  • 34. Obesity and type 2 diabetes: what can be unified and what needs to be individualized?
    Eckel RH; Kahn SE; Ferrannini E; Goldfine AB; Nathan DM; Schwartz MW; Smith RJ; Smith SR; ; ;
    Diabetes Care; 2011 Jun; 34(6):1424-30. PubMed ID: 21602431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity medications and the treatment of type 2 diabetes.
    Greenway F
    Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D; Yanagisawa RT
    Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.
    Garvey WT; Ryan DH; Henry R; Bohannon NJ; Toplak H; Schwiers M; Troupin B; Day WW
    Diabetes Care; 2014 Apr; 37(4):912-21. PubMed ID: 24103901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of type 2 diabetes and its complications].
    Paquot N
    Rev Med Liege; 2024 Jun; 79(5-6):400-404. PubMed ID: 38869130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.